Tilokani, L., Nagashima, S., Paupe, V
Injectable and IV Glutathione: Off-Label Use vs Unapproved Drug Injectable glutathione is not FDA-approved as a drug product, which means it cannot be marketed, sold, or administered as a treatment for any medical condition without meeting the criteria for lawful off-label prescribing
To elucidate this concept, clinical cases have revealed that COVID-19 infection in G6PD-deficient patients could further elevate the risk of such events, leading to more severe clinical outcomes such as intravascular and extravascular hemolysis [1, 10, 44, 45]
- Ung tt nht ngay sau ba n
7th revision of the declaration of Helsinki: good news for the transparency of clinical trials
Available from: [18] Laukkarinen J, Sand J, Aittomki S, Prsti I, Kbi P, Kalliovalkama J, et al